(Australia-NewsWire.Com, July 31, 2018 ) The Global Tumor Ablation Market was worth USD 0.48 million in 2018 and estimated to be growing at a CAGR of 12.97%, to reach USD 0.88 million by 2023. Tumor ablation could be a minimally invasive, image-guided treatment procedure that's wont to destroy cancer cells within the chest, lung, and liver. The horrific increase within the incidence of cancer and, notably, the rising prevalence of growth in humans. The continual advancements in ablation technology, resulting in the accrued development of latest and innovative merchandise that square measure the safe, efficient, and have stripped aspect effects, are boosting the expansion of the world marketplace for growth ablation considerably.
Early buyers will receive 10% customization on reports.
By Technology, the Radiofrequency Ablation Devices segment accounted for the largest share of the market in 2016
On the basis of Technology, the Tumor Ablation Market has been segmented into Radiofrequency Ablation Devices, Microwave Ablation Devices, Cry ablation Devices and other Ablation Devices. In 2016, the Radiofrequency Ablation Devices phase accounted for the most important share of the worldwide growth Ablation Market. Growth during this phase is principally driven by the convenience of treatment, efficiency, and safety. On the opposite hand Microwave Ablation Devices phase is predicted to grow its market with a high CAGR within the forecast amount.
On the basis of treatment, the Tumor Ablation Market has been segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. On the basis of process, the Tumor Ablation Market has been segmented into library preparation, sequencing and data analysis.
North America contributed the major share of the Tumor Ablation Market in 2016, which is followed by Europe. The large share of the North American Tumor Ablation Market can be attributed to the growth in awareness towards cancer and other diseases.
The various players in the Genomics market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.